Breast Cancer Treatment: What’s the Latest?

Not only are more effective drugs for breast cancer coming to the clinic, but oncologists are making important progress in matching breast cancer treatment to specific patients and the molecular characteristics of their tumors. It’s also becoming more feasible to rachet the intensity of treatment up or down depending on the patient’s risk status, and … Read more

For Metastatic Breast Cancer Patient, DF/BWCC Milford ‘Feels Like Family’

As a breast cancer survivor living an hour away from Boston, Deb Ragosta was thrilled when Milford Regional Medical Center – located just a few minutes from her Hopedale, Mass., home – became affiliated with Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) in 2008. While she had completed active treatment in 1995, she knew the partnership … Read more

A New Approach to Understanding Breast Cancer Treatment Resistance

By Srivani Ravoori, PhD, American Association for Cancer Research This post first appeared on the Cancer Today website. In a study presented Dec. 7 at the San Antonio Breast Cancer Symposium, researchers conducted genomic analysis of estrogen receptor (ER)-positive metastatic breast cancer samples that had become resistant to therapies. They found multiple alterations that were not … Read more

Cancer Conversations Podcast – Episode #5: What’s New in Metastatic Breast Cancer Treatment and Research

Although there is no cure for metastatic breast cancer, new developments in treatment and research are helping patients live longer and experience a better quality of life. In this Cancer Conversations podcast episode, Eric Winer, MD, director of Breast Oncology Program in the Susan F. Smith Center for Women’s Cancers at Dana-Farber, discusses the latest … Read more

I Have Metastatic Breast Cancer: What Is My Prognosis?

A metastatic breast cancer diagnosis can be a stressful, life-changing event. While metastatic breast cancer it is not curable, it is treatable. Today, with the help of new treatments including biologic targeted therapies and novel drug combinations, many patients with metastatic disease can live well for years.  Metastatic breast cancer means that the cancer has … Read more

FDA Approves New Therapy for Metastatic Breast Cancer

The U.S. Food and Drug Administration has approved a new treatment  for women with advanced (metastatic) breast cancer. The new therapy, palbociclib, will be used to treat postmenopausal women with metastatic estrogen receptor-positive (ER-positive) breast cancer who have not received previous treatment. Palbociclib, which is marketed under the name Ibrance, will be used in combination … Read more